San Francisco, CA, United States of America

Andrew A Protter

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2016-2018

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Andrew A. Protter

Introduction

Andrew A. Protter is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of cancer treatment, particularly focusing on breast cancer. With a total of 2 patents, Protter's work is recognized for its potential impact on medical therapies.

Latest Patents

Protter's latest patents revolve around the treatment of breast cancer. One of his disclosures describes the use of various compounds that fall within specific structural formulae for treating triple negative breast cancer. These compounds are designed to inhibit the proliferation of breast cancer cells and promote their death, particularly in cases of triple negative breast cancer. This innovative approach highlights Protter's commitment to advancing cancer treatment methodologies.

Career Highlights

Throughout his career, Protter has worked with prominent organizations such as Medivation Prostate Therapeutics, Inc. and the University of Colorado. His experience in these institutions has allowed him to collaborate with leading experts in the field, further enhancing his contributions to cancer research and treatment.

Collaborations

Protter has collaborated with notable colleagues, including Jennifer Richer and Dawn Cochrane. These partnerships have played a crucial role in the development of his innovative ideas and patents.

Conclusion

Andrew A. Protter's work in the field of breast cancer treatment exemplifies the importance of innovation in medical research. His patents and collaborations reflect a dedication to improving patient outcomes and advancing therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…